Inactive Instrument

Biondvax Pharmaceuticals Ltd Share Price

Stocks

End-of-day quote TEL AVIV STOCK EXCHANGE
- ^ILa	-

16/19/16	Biondvax Pharmaceuticals : Announces Rights Offering Fully Subscribed at US$20 Million	PU
08/19/08	Biondvax Pharmaceuticals : First Participant Enrolled in Second Cohort of BiondVax’s Pivotal, Clinical Efficacy, Phase 3 Universal Flu Vaccine Trial	PU
26/19/26	Biondvax Pharmaceuticals : European Investment Bank VP attends Signature Event at BiondVax Extending Financing Agreement with BiondVax to €24 million	PU
18/19/18	Biondvax Pharmaceuticals : Patent Covering Manufacturing Process of BiondVax’s M-001 Universal Flu Vaccine Allowed in USA and Japan	PU
10/19/10	Biondvax Pharmaceuticals : Announces Rights Offering in Support of Ongoing Pivotal, Clinical Efficacy Phase 3 Trial of the M-001 Universal Flu Vaccine and Scale Up of Manufacturing Process	PU

Manager	Title	Age	Since
Amir Reichman CEO	Chief Executive Officer	51	02/03/2021
Uri Ben-Or DFI	Director of Finance/CFO	55	01/01/2007
Dalit Fischer CTO	Chief Tech/Sci/R&D Officer	-	01/01/2022

Director	Title	Age	Since
Mark Germain CHM	Chairman	77	30/09/2019
Samuel Moed BRD	Director/Board Member	64	24/03/2020
Adi Raviv BRD	Director/Board Member	71	24/03/2020

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
LONZA GROUP AG	+2.64%	+7.07%	+11.87%	+38.40%	4.8TCr
IQVIA HOLDINGS INC.	+0.22%	+0.40%	+50.91%	+37.06%	4.45TCr
REVOLUTION MEDICINES, INC.	-1.58%	+4.66%	+359.34%	+614.38%	4.39TCr
BEONE MEDICINES AG	+1.70%	+0.36%	+12.56%	+99.27%	4.1TCr
CELLTRION, INC.	+0.51%	-0.61%	+5.18%	+46.87%	2.99TCr
MEDPACE HOLDINGS, INC.	-0.48%	-1.32%	+23.98%	+150.01%	1.73TCr
TEMPUS AI, INC.	+0.08%	+9.03%	+8.41%	-	1.53TCr
EUROFINS SCIENTIFIC SE	+1.76%	+0.85%	+29.13%	+48.42%	1.53TCr
ASCENDIS PHARMA A/S	+1.97%	-3.17%	-	-	1.48TCr
Average	+0.76%	+2.34%	+62.67%	+147.77%	3TCr
Weighted average by Cap.	+0.74%	+2.80%	+79.47%	+163.79%

Employees

Sector